Dr. Alain Bouchard and Dr. Martha Gulati delve into everything you ever wanted to know about primary prevention with this week’s focus: Aspirin No ratings yet. Tell Us How We're Doing… Was This Article Helpful?
“Preventing Heart Disease: Identifying and Mitigating Risk Factors for a Healthier Future”
Heart disease is a major public health concern worldwide, and primary prevention of heart disease is essential to reducing its incidence. Primary prevention refers to measures that are taken to prevent the development of a disease before it occurs. This approach to prevention is particularly important for heart disease because once the disease develops, it […]
FACTOR XI, A PROMISING ANTICOAGULANT
Blood clot disorders are estimated to cause 1 in 4 deaths. Blood clots are associated with pulmonary embolism, most cases of heart attack and stroke, and are a major cause of morbidity and mortality in the US. Anticoagulation therapy is the foundation for the prevention and treatment of blood clots. For many years, warfarin, or […]
THE RISING STAR: FACTOR XI
THE RISING STAR: FACTOR XI, A PROMISING ANTICOAGULANT FOR THE FUTURE Featuring: Michael Gibson M.S., M.D. – Chief Executive Officer, Baim Institute for Clinical ResearchKenneth Mahaffey M.D. – Professor – Stanford, Medicine – Cardiovascular Medicine No ratings yet. Tell Us How We're Doing… Was This Article Helpful?
Primary Prevention Episode 1: How to identify people at risk for heart disease.
Dr. Alain Bouchard and Dr. Martha Gulati delve into everything you ever wanted to know about primary prevention with this week’s focus: Prevention No ratings yet. Tell Us How We're Doing… Was This Article Helpful?
FH: TREATMENT AND POTENTIAL CURE?
FAMILIAL HYPERCHOLESTEROLEMIA (FH): TREATMENT AND POTENTIAL CURE? What is Familial Hypercholesterolemia or FH? FH is an autosomal dominant inherited genetic condition that involves approximately 30 million patients across the world. It is underdiagnosed with only 15% of Americans with FH having received the diagnosis. FH is caused by an abnormal variant of one or more […]
Familial Hypercholesterolemia with Dr. Pradeep Natarajan
Dr. Bouchard discusses “Familial Hypercholesterolemia” with Dr. Pradeep Natarajan from Harvard. 5/5 (1) Tell Us How We're Doing… Was This Article Helpful?
Arts in Health with Dr. Julian Owens
Dr. Bouchard discusses “Arts in Health” with Dr. Julian Owens. 5/5 (1) Tell Us How We're Doing… Was This Article Helpful?
Hypertension with Dr. Suzanne Oparil
Dr. Bouchard discusses ” Hypertension” with Dr. Suzanne Oparil, M.D. Distinguished Professor of Medicine. Professor of Cell, Developmental and Integrative Biology Director, Vascular Biology and Hypertension Program. Section Chief of Vascular Biology and Hypertension. Hypertension is a pervasive problem and affects nearly 50% of the US population including over 90 million adults with uncontrolled hypertension and an […]
ARTS IN HEALTH AND MEDICINE
This article was written in collaboration with Kimberly Kirklin, Director of UAB Arts In Medicine, and Dr Rachel Easterwood, a Hospitalist with Mount Sinai Health System in New York. ARTS IN HEALTH Arts in Health is a diverse, multidisciplinary approach dedicated to improving health through arts. The field integrates visual arts and design, musical, literary, […]
HYPERTENSION, THE SILENT KILLER
This article was written in collaboration with Dr. Suzanne Oparil, M.D. Distinguished Professor of Medicine. Professor of Cell, Developmental and Integrative Biology. Director, Vascular Biology and Hypertension Program. Section Chief of Vascular Biology and Hypertension, at the University of Alabama at Birmingham. HYPERTENSION, THE SILENT KILLER Hypertension is a pervasive problem and affects nearly 50% of […]
HDL Conundrum with Dr John J.P. Kastelein
Dr. Bouchard discusses ” THE HDL CHOLESTEROL CONUNDRUM” with Dr. John J.P. Kastelein, M.D., Ph.D., FESC, Professor of Medicine, University of Amsterdam. For the last 15 yrs, multiple randomized controlled trials have attempted to improve clinical outcomes by raising HDL cholesterol and have failed to achieve any significant results. The studies of niacin and fibrates have […]
THE HDL CHOLESTEROL CONUNDRUM
THE HDL CHOLESTEROL CONUNDRUM The role of High-density lipoprotein (HDL) cholesterol in the development of atherosclerosis and cardiovascular (CV) morbidity and mortality has long been recognized. Epidemiological studies have demonstrated an inverse relationship between HDL cholesterol and CV events. HDL is incorporated in the calculation of the 10-yr ASCVD risk in patients who have never […]
NON-STATIN TREATMENT FOR CHOLESTEROL
This article was written in collaboration with Dr. John J.P. Kastelein, M.D., Ph.D., FESC.Professor of Medicine, University of Amsterdam. NON-STATIN THERAPIES FOR LDL CHOLESTEROL LOWERING The role of statin in the treatment of patients with atherosclerotic cardiovascular disease (ASCVD) has been well demonstrated to lower major cardiovascular events. It is the number one recommendation by […]
Non-Statin Treatment for LDL Cholesterol with Dr. John J.P. Kastelein
Dr. Bouchard discusses “Non-Statin Treatment for LDL Cholesterol ” with Dr. John J.P. Kastelein, M.D., Ph.D., FESC. Professor of Medicine, University of Amsterdam. Despite the 30 years of advances in lipid management and more patients being treated with a statin, approximately 70% of our patients still remain at risk of developing an ASCVD event: In the […]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 25
- Next Page »